Part 1
Part 2
Part 3
Part 4
Part 5
Description
Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.
Market Analysis and Insights: Global Biologics Contract Manufacturing Market
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Biologics Contract Manufacturing include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, SamsungBiologics, Abbvie, Catalent and Bioreliance, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Biologics Contract Manufacturing is widely used in various fields, such as Oncology, Immunological Disorders, Cardiovascular Disorders (CVDs) and Hematological Disorders, etc. Oncology provides greatest supports to the Biologics Contract Manufacturing industry development. In 2023, global % revenue of Biologics Contract Manufacturing went into Oncology filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biologics Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biologics Contract Manufacturing, also provides the revenue of main regions and countries. of the upcoming market potential for Biologics Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologics Contract Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biologics Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biologics Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
Report Metric
Details
Report Title
Global Biologics Contract Manufacturing Market Insights, Forecast to 2030
Market Size Available for Years
2024-2030
Global Biologics Contract Manufacturing Companies Covered
Wuxi Biologics
Abzena Ltd.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Boehringer Ingelheim GmbH
Lonza
SamsungBiologics
Abbvie
Catalent
Bioreliance
Thermo Fischer (Patheon)
Eurofins CDMO
Global Biologics Contract Manufacturing Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologics Contract Manufacturing Market, Segment by Type
MABs
Recombinant Protein
Others
Global Biologics Contract Manufacturing Market, Segment by Application
Oncology
Immunological Disorders
Cardiovascular Disorders (CVDs)
Hematological Disorders
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biologics Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MABs
1.2.3 Recombinant Protein
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Immunological Disorders
1.3.4 Cardiovascular Disorders (CVDs)
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Manufacturing Market Perspective (2019-2030)
2.2 Global Biologics Contract Manufacturing Growth Trends by Region
2.2.1 Biologics Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Biologics Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Biologics Contract Manufacturing Market Dynamics
2.3.1 Biologics Contract Manufacturing Industry Trends
2.3.2 Biologics Contract Manufacturing Market Drivers
2.3.3 Biologics Contract Manufacturing Market Challenges
2.3.4 Biologics Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biologics Contract Manufacturing by Players
3.1.1 Global Biologics Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biologics Contract Manufacturing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biologics Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biologics Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Manufacturing Revenue in 2023
3.5 Global Key Players of Biologics Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Biologics Contract Manufacturing, Product and Application
3.7 Global Key Players of Biologics Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Manufacturing Breakdown Data by Type
4.1 Global Biologics Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Biologics Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Biologics Contract Manufacturing Breakdown Data by Application
5.1 Global Biologics Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Biologics Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Contract Manufacturing Market Size (2019-2030)
6.2 North America Biologics Contract Manufacturing Market Size by Type
6.2.1 North America Biologics Contract Manufacturing Market Size by Type (2019-2024)
6.2.2 North America Biologics Contract Manufacturing Market Size by Type (2025-2030)
6.2.3 North America Biologics Contract Manufacturing Market Share by Type (2019-2030)
6.3 North America Biologics Contract Manufacturing Market Size by Application
6.3.1 North America Biologics Contract Manufacturing Market Size by Application (2019-2024)
6.3.2 North America Biologics Contract Manufacturing Market Size by Application (2025-2030)
6.3.3 North America Biologics Contract Manufacturing Market Share by Application (2019-2030)
6.4 North America Biologics Contract Manufacturing Market Size by Country
6.4.1 North America Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biologics Contract Manufacturing Market Size by Country (2019-2024)
6.4.3 North America Biologics Contract Manufacturing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biologics Contract Manufacturing Market Size (2019-2030)
7.2 Europe Biologics Contract Manufacturing Market Size by Type
7.2.1 Europe Biologics Contract Manufacturing Market Size by Type (2019-2024)
7.2.2 Europe Biologics Contract Manufacturing Market Size by Type (2025-2030)
7.2.3 Europe Biologics Contract Manufacturing Market Share by Type (2019-2030)
7.3 Europe Biologics Contract Manufacturing Market Size by Application
7.3.1 Europe Biologics Contract Manufacturing Market Size by Application (2019-2024)
7.3.2 Europe Biologics Contract Manufacturing Market Size by Application (2025-2030)
7.3.3 Europe Biologics Contract Manufacturing Market Share by Application (2019-2030)
7.4 Europe Biologics Contract Manufacturing Market Size by Country
7.4.1 Europe Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biologics Contract Manufacturing Market Size by Country (2019-2024)
7.4.3 Europe Biologics Contract Manufacturing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biologics Contract Manufacturing Market Size (2019-2030)
8.2 China Biologics Contract Manufacturing Market Size by Type
8.2.1 China Biologics Contract Manufacturing Market Size by Type (2019-2024)
8.2.2 China Biologics Contract Manufacturing Market Size by Type (2025-2030)
8.2.3 China Biologics Contract Manufacturing Market Share by Type (2019-2030)
8.3 China Biologics Contract Manufacturing Market Size by Application
8.3.1 China Biologics Contract Manufacturing Market Size by Application (2019-2024)
8.3.2 China Biologics Contract Manufacturing Market Size by Application (2025-2030)
8.3.3 China Biologics Contract Manufacturing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biologics Contract Manufacturing Market Size (2019-2030)
9.2 Asia Biologics Contract Manufacturing Market Size by Type
9.2.1 Asia Biologics Contract Manufacturing Market Size by Type (2019-2024)
9.2.2 Asia Biologics Contract Manufacturing Market Size by Type (2025-2030)
9.2.3 Asia Biologics Contract Manufacturing Market Share by Type (2019-2030)
9.3 Asia Biologics Contract Manufacturing Market Size by Application
9.3.1 Asia Biologics Contract Manufacturing Market Size by Application (2019-2024)
9.3.2 Asia Biologics Contract Manufacturing Market Size by Application (2025-2030)
9.3.3 Asia Biologics Contract Manufacturing Market Share by Application (2019-2030)
9.4 Asia Biologics Contract Manufacturing Market Size by Region
9.4.1 Asia Biologics Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biologics Contract Manufacturing Market Size by Region (2019-2024)
9.4.3 Asia Biologics Contract Manufacturing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Wuxi Biologics
11.1.1 Wuxi Biologics Company Details
11.1.2 Wuxi Biologics Business Overview
11.1.3 Wuxi Biologics Biologics Contract Manufacturing Introduction
11.1.4 Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.1.5 Wuxi Biologics Recent Developments
11.2 Abzena Ltd.
11.2.1 Abzena Ltd. Company Details
11.2.2 Abzena Ltd. Business Overview
11.2.3 Abzena Ltd. Biologics Contract Manufacturing Introduction
11.2.4 Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.2.5 Abzena Ltd. Recent Developments
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Details
11.4.2 Boehringer Ingelheim GmbH Business Overview
11.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Introduction
11.4.4 Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.4.5 Boehringer Ingelheim GmbH Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Biologics Contract Manufacturing Introduction
11.5.4 Lonza Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.5.5 Lonza Recent Developments
11.6 SamsungBiologics
11.6.1 SamsungBiologics Company Details
11.6.2 SamsungBiologics Business Overview
11.6.3 SamsungBiologics Biologics Contract Manufacturing Introduction
11.6.4 SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.6.5 SamsungBiologics Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Biologics Contract Manufacturing Introduction
11.7.4 Abbvie Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.7.5 Abbvie Recent Developments
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Biologics Contract Manufacturing Introduction
11.8.4 Catalent Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.8.5 Catalent Recent Developments
11.9 Bioreliance
11.9.1 Bioreliance Company Details
11.9.2 Bioreliance Business Overview
11.9.3 Bioreliance Biologics Contract Manufacturing Introduction
11.9.4 Bioreliance Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.9.5 Bioreliance Recent Developments
11.10 Thermo Fischer (Patheon)
11.10.1 Thermo Fischer (Patheon) Company Details
11.10.2 Thermo Fischer (Patheon) Business Overview
11.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Introduction
11.10.4 Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.10.5 Thermo Fischer (Patheon) Recent Developments
11.11 Eurofins CDMO
11.11.1 Eurofins CDMO Company Details
11.11.2 Eurofins CDMO Business Overview
11.11.3 Eurofins CDMO Biologics Contract Manufacturing Introduction
11.11.4 Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2019-2024)
11.11.5 Eurofins CDMO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table of Figures
List of Tables
Table 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of MABs
Table 3. Key Players of Recombinant Protein
Table 4. Key Players of Others
Table 5. Global Biologics Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Biologics Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biologics Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Biologics Contract Manufacturing Market Share by Region (2019-2024)
Table 9. Global Biologics Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Biologics Contract Manufacturing Market Share by Region (2025-2030)
Table 11. Biologics Contract Manufacturing Market Trends
Table 12. Biologics Contract Manufacturing Market Drivers
Table 13. Biologics Contract Manufacturing Market Challenges
Table 14. Biologics Contract Manufacturing Market Restraints
Table 15. Global Biologics Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Biologics Contract Manufacturing Revenue Share by Players (2019-2024)
Table 17. Global Top Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2023)
Table 18. Global Biologics Contract Manufacturing Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Biologics Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Biologics Contract Manufacturing, Headquarters and Area Served
Table 21. Global Key Players of Biologics Contract Manufacturing, Product and Application
Table 22. Global Key Players of Biologics Contract Manufacturing, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Biologics Contract Manufacturing Revenue Market Share by Type (2019-2024)
Table 26. Global Biologics Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Biologics Contract Manufacturing Revenue Market Share by Type (2025-2030)
Table 28. Global Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Biologics Contract Manufacturing Revenue Share by Application (2019-2024)
Table 30. Global Biologics Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Biologics Contract Manufacturing Revenue Share by Application (2025-2030)
Table 32. North America Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Biologics Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Biologics Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Biologics Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biologics Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 64. Wuxi Biologics Company Details
Table 65. Wuxi Biologics Business Overview
Table 66. Wuxi Biologics Biologics Contract Manufacturing Product
Table 67. Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 68. Wuxi Biologics Recent Developments
Table 69. Abzena Ltd. Company Details
Table 70. Abzena Ltd. Business Overview
Table 71. Abzena Ltd. Biologics Contract Manufacturing Product
Table 72. Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 73. Abzena Ltd. Recent Developments
Table 74. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
Table 75. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 76. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product
Table 77. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 78. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
Table 79. Boehringer Ingelheim GmbH Company Details
Table 80. Boehringer Ingelheim GmbH Business Overview
Table 81. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product
Table 82. Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 83. Boehringer Ingelheim GmbH Recent Developments
Table 84. Lonza Company Details
Table 85. Lonza Business Overview
Table 86. Lonza Biologics Contract Manufacturing Product
Table 87. Lonza Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 88. Lonza Recent Developments
Table 89. SamsungBiologics Company Details
Table 90. SamsungBiologics Business Overview
Table 91. SamsungBiologics Biologics Contract Manufacturing Product
Table 92. SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 93. SamsungBiologics Recent Developments
Table 94. Abbvie Company Details
Table 95. Abbvie Business Overview
Table 96. Abbvie Biologics Contract Manufacturing Product
Table 97. Abbvie Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 98. Abbvie Recent Developments
Table 99. Catalent Company Details
Table 100. Catalent Business Overview
Table 101. Catalent Biologics Contract Manufacturing Product
Table 102. Catalent Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 103. Catalent Recent Developments
Table 104. Bioreliance Company Details
Table 105. Bioreliance Business Overview
Table 106. Bioreliance Biologics Contract Manufacturing Product
Table 107. Bioreliance Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 108. Bioreliance Recent Developments
Table 109. Thermo Fischer (Patheon) Company Details
Table 110. Thermo Fischer (Patheon) Business Overview
Table 111. Thermo Fischer (Patheon) Biologics Contract Manufacturing Product
Table 112. Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 113. Thermo Fischer (Patheon) Recent Developments
Table 114. Eurofins CDMO Company Details
Table 115. Eurofins CDMO Business Overview
Table 116. Eurofins CDMO Biologics Contract Manufacturing Product
Table 117. Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 118. Eurofins CDMO Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Biologics Contract Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. MABs Features
Figure 4. Recombinant Protein Features
Figure 5. Others Features
Figure 6. Global Biologics Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Biologics Contract Manufacturing Market Share by Application: 2023 VS 2030
Figure 8. Oncology Case Studies
Figure 9. Immunological Disorders Case Studies
Figure 10. Cardiovascular Disorders (CVDs) Case Studies
Figure 11. Hematological Disorders Case Studies
Figure 12. Others Case Studies
Figure 13. Biologics Contract Manufacturing Report Years Considered
Figure 14. Global Biologics Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Biologics Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Biologics Contract Manufacturing Market Share by Region: 2023 VS 2030
Figure 17. Global Biologics Contract Manufacturing Market Share by Players in 2023
Figure 18. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Biologics Contract Manufacturing Revenue in 2023
Figure 20. North America Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Biologics Contract Manufacturing Market Share by Type (2019-2030)
Figure 22. North America Biologics Contract Manufacturing Market Share by Application (2019-2030)
Figure 23. North America Biologics Contract Manufacturing Market Share by Country (2019-2030)
Figure 24. United States Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Biologics Contract Manufacturing Market Share by Type (2019-2030)
Figure 28. Europe Biologics Contract Manufacturing Market Share by Application (2019-2030)
Figure 29. Europe Biologics Contract Manufacturing Market Share by Country (2019-2030)
Figure 30. Germany Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Biologics Contract Manufacturing Market Share by Type (2019-2030)
Figure 38. China Biologics Contract Manufacturing Market Share by Application (2019-2030)
Figure 39. Asia Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Biologics Contract Manufacturing Market Share by Type (2019-2030)
Figure 41. Asia Biologics Contract Manufacturing Market Share by Application (2019-2030)
Figure 42. Asia Biologics Contract Manufacturing Market Share by Region (2019-2030)
Figure 43. Japan Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Biologics Contract Manufacturing Market Share by Country (2019-2030)
Figure 53. Brazil Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Biologics Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Wuxi Biologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 60. Abzena Ltd. Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 61. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 63. Lonza Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 64. SamsungBiologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 65. Abbvie Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 66. Catalent Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 67. Bioreliance Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 68. Thermo Fischer (Patheon) Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 69. Eurofins CDMO Revenue Growth Rate in Biologics Contract Manufacturing Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives InterviewedDescription
Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.
Market Analysis and Insights: Global Biologics Contract Manufacturing Market
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Biologics Contract Manufacturing include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, SamsungBiologics, Abbvie, Catalent and Bioreliance, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Biologics Contract Manufacturing is widely used in various fields, such as Oncology, Immunological Disorders, Cardiovascular Disorders (CVDs) and Hematological Disorders, etc. Oncology provides greatest supports to the Biologics Contract Manufacturing industry development. In 2023, global % revenue of Biologics Contract Manufacturing went into Oncology filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biologics Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biologics Contract Manufacturing, also provides the revenue of main regions and countries. of the upcoming market potential for Biologics Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologics Contract Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biologics Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biologics Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biologics Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Related Reports
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
Published: 2024-02-26
Pages: 87
USD 2900.00
(Single User License)
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
Published: 2024-01-11
Pages: 102
USD 3950.00
(Single User License)
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 144
USD 4900.00
(Single User License)
The global Biologics Contract Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 94
USD 4250.00
(Single User License)
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
Published: 2024-02-26
Pages: 87
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
Published: 2024-01-11
Pages: 102
The global Biologics Contract Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 144
The global Biologics Contract Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 94
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database